These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36452274)
21. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis. Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of the Phospholipase Cε-c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties. Okada M; Nakagawa-Saito Y; Mitobe Y; Sugai A; Togashi K; Suzuki S; Kitanaka C Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955917 [TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714 [TBL] [Abstract][Full Text] [Related]
24. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1. Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824 [TBL] [Abstract][Full Text] [Related]
25. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells. Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970 [TBL] [Abstract][Full Text] [Related]
26. Ribosomal protein S6 promotes stem-like characters in glioma cells. Shirakawa Y; Hide T; Yamaoka M; Ito Y; Ito N; Ohta K; Shinojima N; Mukasa A; Saito H; Jono H Cancer Sci; 2020 Jun; 111(6):2041-2051. PubMed ID: 32246865 [TBL] [Abstract][Full Text] [Related]
27. Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells. Zorniak M; Clark PA; Kuo JS J Neurosurg; 2015 Jan; 122(1):69-77. PubMed ID: 25361488 [TBL] [Abstract][Full Text] [Related]
28. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells. Han D; Yu T; Dong N; Wang B; Sun F; Jiang D J Exp Clin Cancer Res; 2019 Jul; 38(1):289. PubMed ID: 31277685 [TBL] [Abstract][Full Text] [Related]
29. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production. Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296 [TBL] [Abstract][Full Text] [Related]
30. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059 [TBL] [Abstract][Full Text] [Related]